A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first moment for medical research and drug development.

Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging one of the UK's most powerful supercomputers, Dawn.

Researchers at the University of Cambridge have developed the first-ever vaccine component designed entirely by artificial intelligence, now trialled in humans.

A new AI-designed vaccine capable of protecting against entire families of viruses could transform how the world prepares for a future pandemic.

AI-designed ‘super-antigen’ vaccine passes first human trial, raising hopes for future-proof protection against coronavirus families and emerging pandemics.

A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first moment for medical research and drug development.

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab aims to protect against a wide range of…

Lo studio dell'Università di Cambridge punta a sviluppare vaccini universali contro coronavirus, influenza ed Ebola, con l'obiettivo di prevenire future pandem…

Cambridge scientists have successfully completed the first human trial of an AI-designed universal coronavirus vaccine, aiming to protect against future pa

pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.

The world has just crossed another major threshold in science and medicine. For decades, vaccines were developed through long cycles

The experimental jab is intended to target a wide range of viruses, including those behind deadly outbreaks like Sars, Mers and Covid-19.

Cientistas de Cambridge dizem ter testado pela primeira vez em pessoas uma vacina projetada por IA

Targets entire family of viruses, animal-borne strains; aims to thwart future pandemics; initial-phase trials of 39 participants succeeded; larger efficacy studies loom.

University of Cambridge completes first human trial of an AI-designed vaccine targeting all coronaviruses, showing safety and immune responses in 39

University of Cambridge completes first human trial of an AI-designed vaccine, showing safety and broad immune response against multiple coronaviruses in 39

Cambridge researchers used AI to design a 'universal vaccine' that may protect against thousands of viruses and future mutations; first human trial found it safe and able to…